Kazia Therapeutics (KZIA) Operating Income (2009)
Kazia Therapeutics (KZIA) reported Operating Income of $15.32 million for the year ended Jun 30, 2011, down 8.3% from $16.71 million a year earlier.
Powered by 
Analysis
Kazia Therapeutics (KZIA) Operating Income (2009) Analysis & Trends
- According to Business Quant data, Operating Income came in at $16.71 million in the year ended Jun 30, 2010 and $27.03 million in the year ended Dec 31, 2009.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,169.76 Bn | 1,138.35 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 648.06 Bn | 567.92 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 503.37 Bn | 476.48 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 365.39 Bn | 319.77 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 303.45 Bn | 267.44 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 269.03 Bn | 242.72 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 242.08 Bn | 197.48 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 194.88 Bn | 169.07 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 172.39 Bn | 119.04 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Kazia Therapeutics | 592,289.89 | -51.78 Mn | - | - |
API Access
Kazia Therapeutics Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=KZIA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "KZIA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=KZIA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();